Jessica Frau

9PUBLICATIONS
24CO-AUTHORS
Contract lawApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanotoxicology, health and safetyRegenerative medicine (incl. stem cells)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 29, 2024
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop).

Irene Schiavetti, Alessio Signori, Angela Albanese

|May 08, 2023
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?

Irene Schiavetti, Matilde Inglese, Jessica Frau

|Oct 19, 2022
Change in upper limb function in people with multiple sclerosis treated with nabiximols: a quantitative kinematic pilot study.

Massimiliano Pau, Micaela Porta, Gabriella Spinicci

|Sep 24, 2021
A real-world study of alemtuzumab in a cohort of Italian patients.

Cinzia Valeria Russo, Francesco Saccà, Jessica Frau

|Jun 17, 2021
What happens after fingolimod discontinuation? A multicentre real-life experience.

Doriana Landi, Alessio Signori, Maria Cellerino

|Mar 14, 2019
Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis.

Jessica Frau, Giancarlo Coghe, Lorena Lorefice

Pageof 2